Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

PDMR Notification

18 Mar 2021 09:02

RNS Number : 7033S
Conduit Holdings Limited
18 March 2021
 

This announcement contains inside information for the purpose of Article 7 of the Market Abuse Regulation (EU) No 596/2014 (the "Market Abuse Regulation").

 

Conduit Holdings Limited ("Conduit Holdings")

 

Hamilton, Bermuda March 18, 2021

 

PDMR Notification

Conduit Holdings today announces that Richard Sandor, a Director and a person discharging managerial responsibilities in Conduit Holdings ("PDMR"), on 2 March 2021, acquired 1,000 Conduit Holdings common shares of par value $0.01 per share each at a price of 5.48 pence per share. Richard's total current shareholding is 1,000 common shares.

PDMR Notification of Dealing Form: The notification below, made in accordance with the requirements of the Market Abuse Regulation, provides further details of the transaction.

1

Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")

a)

Name

Dr Richard Sandor

2

Reason for the Notification

a)

Position/status

 

PDMR

Director

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Conduit Holdings Limited

b)

LEI

213800VO4O83JVSSOX33

4

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of

instrument

Common Shares of $0.01 par value

 

Identification code

ISIN BMG243851091

SEDOL BN133N2

b)

Nature of the Transaction

 

 

Acquisition of Shares

c)

Price(s) and volume(s)

 

Price(s)

GBP 5.48

Volume(s)

1,000

 

d)

Aggregated information

 

 

Aggregated volume

 

 

 

Price

1,000 Common Shares in aggregate

 

£5,493.70 aggregated total

 

 

£5.48 per Common Share

e)

Date of the transaction

March 2, 2021

f)

Place of the transaction

London Stock Exchange (XLON)

 

ENDS

 

 

Contacts

 

Media: David Haggie, Caroline Klein, Haggie Partners +44 (0) 207 562 4444 ConduitRe@haggie.co.uk 

 

Other: info@conduitreinsurance.com 

 

Website

 

Further details of the Conduit Group can be found at its website: https://conduitreinsurance.com/ 

 

Notes to Editors

 

About Conduit Re

 

· Conduit Re is a newly established reinsurance underwriting business focusing on producing strong risk-adjusted returns from a diversified and focused business plan. The business has been formed to capitalise on what the Company's founders, Neil Eckert and Trevor Carvey (the "Founders") believe to be an exceptional market opportunity.

· Conduit Re writes reinsurance in the property, casualty and specialty classes. Years of high insured losses, diminished reserves and the more recent losses and industry strain caused by Covid-19 and severe capacity shortages in certain classes of insurance and reinsurance have produced major corrections in reinsurance pricing and policy Terms & Conditions.

· Against the industry background of losses, litigation and capacity constraint, as a new business, Conduit has no legacy exposure and its strong and unencumbered balance sheet is available to write new business in what the Founders believe to be an attractive market environment.

· Conduit Re is led by two highly successful, experienced and networked industry executives, Neil Eckert and Trevor Carvey.

· Conduit Re has been established to build a strong underwriting franchise which will target strong cross-cycle returns on equity in the mid-teens. The business plan has a balanced approach to catastrophe risk exposures, generating profit and franchise value through the quality of its underwriting and its select portfolio of high quality business.

· Conduit Re expects to generate significant returns for its shareholders and to provide an ongoing and progressive dividend. The Company is targeting a dividend as soon as during the 2021 financial year of approximately 5% - 6% of equity capital, allocated between an interim and final distribution. Conduit will manage its balance sheet efficiently and in the long term may return excess capital through special dividends or share buybacks where appropriate.

· Following years of de-listings, in weak industry conditions and upon industry consolidation, Conduit Re offers investors the opportunity to take advantage of prevailing, highly positive industry conditions through investment in a listed business which is legacy free and focused only on reinsurance.

· Conduit Re believes that sound ESG principles should be strongly embedded across the business and that this promotes better risk management, innovation, sustainable outperformance and positive community engagement. Conduit Re intends to be a carbon neutral business. Conduit Re will target a Net-Zero position through a combination of sound business practices and strategically chosen offset initiatives.

· A.M. Best has assigned a Financial Strength Rating of A- (Excellent) and a Long-Term Issuer Credit Rating of "a-" to Conduit Reinsurance Limited. The outlook assigned to these Credit Ratings (ratings) is stable.

 

Learn more:

Web: https://conduitreinsurance.com/

LinkedIn: https://www.linkedin.com/company/conduit-re

Twitter: https://twitter.com/Conduit_Re

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGZGMFLRGGMZG
Date   Source Headline
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:59 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSDirector/PDMR Shareholding
27th Jul 20235:20 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSConduit Interim Results 2023
25th Jul 20237:00 amRNSDirectorate Change
14th Jul 20232:55 pmRNSNotice of H1 2023 Results and Conference Call
22nd Jun 20237:00 amRNSNotice of IFRS 17 Briefing Call
15th Jun 20234:48 pmRNSHolding(s) in Company
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSTransfer of Treasury Shares
19th May 20234:56 pmRNSDirector/PDMR Shareholding
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSResults of 2023 AGM
17th May 20237:00 amRNSFirst Quarter 2023 Trading Update
4th May 20234:20 pmRNSNotice of Q1 2023 Trading Update and Webcast
17th Apr 20232:09 pmRNSNotice of AGM
6th Apr 20232:50 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSHolding(s) in Company
7th Mar 20234:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:25 amRNSPublication of 2022 Annual Report and Accounts
22nd Feb 20237:00 amRNSYear ended 31 December 2022 Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.